603669.SHG Lionco Pharm Grp Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
5.47 CNY
Close of Nov 4, 2026
4.01 8.40
Market cap
CNY 3.90B
P/E
-
P/B
5.67x
ROE
6.5%
Dividend yield
0.17%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603669.SHG undervalued?

Graham number

The Graham number of Lionco Pharm Grp Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Lionco Pharm Grp Co Ltd fundamental analysis

No fundamental analysis for Lionco Pharm Grp Co Ltd yet.

Lionco Pharm Grp Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Lionco Pharm Grp Co Ltd

Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, anti-infective drugs, and other applications. Lionco Pharmaceutical Group Co.,Ltd. was founded in 2003 and is based in Shannan, China.

Full company profile